Cardiol Therapeutics Inc.

Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.

CRDL | NDAQ

Overview

Corporate Details

ISIN(s):: CA14161Y2006
LEI:
Country:: United States of America
Address:: 602-2265 UPPER MIDDLE ROAD EAST, OAKVILLE
Website:: https://www.cardiolrx.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Cardiol Therapeutics Inc. is a clinical-stage life sciences company focused on the research and clinical development of novel anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The company develops treatments for underserved cardiovascular conditions, with a primary focus on pericarditis, myocarditis, and heart failure. Its lead product candidate, CardiolRx™, is an orally administered cannabidiol solution designed to target the underlying mechanisms of inflammation and fibrosis in cardiac disease. The company's pipeline also includes preclinical candidates. Cardiol Therapeutics collaborates with international research centers and clinical experts to advance its therapeutic programs for patients with debilitating heart conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Cardiol Therapeutics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cardiol Therapeutics Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Cardiol Therapeutics Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
i-mobile Co.,Ltd. Operates one of Japan's largest ad networks and a 'Furusato Nozei' tax donation website.	Japan	6535
INBIOGEN CO.,Ltd Data mining, bioinformatics, and virtual assistance for the life sciences industry.	South Korea	101140
Incannex Healthcare Inc. Develops oral cannabinoid/psychedelic therapies for sleep apnea, arthritis & anxiety.	United States of America	IXHL
Incross Co.,Ltd. A digital marketing firm offering data-driven ad solutions via proprietary AI and video platforms.	South Korea	216050
INEST,Inc. Offers ASP solutions and HR support to businesses and sells mobile devices to consumers.	Japan	7111
Innate Pharma Clinical-stage biotech developing NK cell-engaging antibodies for cancer immunotherapy.	France	IPH
Innovation Inc. Drives B2B growth via digital media, IT solutions, M&A advisory, and venture capital.	Japan	3970
Innventure, Inc. Founds, funds, and scales companies using breakthrough R&D from multinational corporations.	United States of America	INV
Inotiv, Inc. CRO providing nonclinical drug discovery, research models, and analytical services for life sciences.	United States of America	NOTV
INTAGE HOLDINGS Inc. Marketing research & business intelligence for consumer goods, healthcare & enterprise tech.	Japan	4326